Global DPT Vaccines Market Growth 2023-2029

Global DPT Vaccines Market Growth 2023-2029

The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
LPI (LP Information)' newest research report, the “DPT Vaccines Industry Forecast” looks at past sales and reviews total world DPT Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected DPT Vaccines sales for 2023 through 2029. With DPT Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DPT Vaccines industry.
This Insight Report provides a comprehensive analysis of the global DPT Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DPT Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global DPT Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DPT Vaccines and breaks down the forecast by type, by age, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DPT Vaccines.
The global DPT Vaccines market size is projected to grow from US$ 5075.1 million in 2022 to US$ 6514.2 million in 2029; it is expected to grow at a CAGR of 6514.2 from 2023 to 2029.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
This report presents a comprehensive overview, market shares, and growth opportunities of DPT Vaccines market by product type, age, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
DTaP
Tdap
DTwP
Segmentation by age
12 Months Below
12 Months Above
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology

Key Questions Addressed in this Report
What is the 10-year outlook for the global DPT Vaccines market?
What factors are driving DPT Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DPT Vaccines market opportunities vary by end market size?
How does DPT Vaccines break out type, age?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.